手机验证
/
HBL 100; HBL100
/
充足
/
/
/
/
/
乳腺
人乳腺上皮细胞
人
/
上皮样
/
乳腺
复苏发货或干冰冷冻发货
/
贴壁
1 x 10^6 cells/vial/T25
细胞名称:HBL-100人乳腺上皮细胞(STR鉴定正确)
产品货号:C1276
培养条件:1640+10%FBS+1%PS(货号:M0201)
生长特性:贴壁
细胞形态:上皮样
产品规格:1 x 10^6 cells/vial/T25
产品货号 | 细胞名称 | 中文名称 | 生长特性 | 细胞形态 | 产品规格 |
C1025 | BT-474[BT474] | 人乳腺导管癌细胞 | 贴壁 | 上皮样 | 1 x 10^6 cells/vial/T25 |
C1034 | MDA-MB-453 | 人乳腺癌细胞 | 半悬浮 | 上皮样 | 1 x 10^6 cells/vial/T25 |
C1064 | Hs 578T | 人乳腺癌细胞 | 贴壁 | 上皮样 | 1 x 10^6 cells/vial/T25 |
C1112 | MDA-MB-231 | 人乳腺癌细胞 | 贴壁 | 上皮样 | 1 x 10^6 cells/vial/T25 |
C1119 | SK-BR-3 | 人乳腺腺癌细胞 | 贴壁 | 上皮样 | 1 x 10^6 cells/vial/T25 |
C1127 | MCF 10A | 人乳腺细胞 | 贴壁 | 上皮样 | 1 x 10^6 cells/vial/T25 |
C1156 | MDA-MB-468 | 人乳腺癌细胞 | 贴壁 | 上皮样 | 1 x 10^6 cells/vial/T25 |
C1162 | BT-549 | 人乳腺管癌细胞 | 贴壁 | 上皮样 | 1 x 10^6 cells/vial/T25 |
C1177 | MDA-MB-436 | 人乳腺腺癌细胞 | 贴壁 | 有多核成分的多形细胞 | 1 x 10^6 cells/vial/T25 |
C1199 | HCC1937 | 人乳腺癌细胞 | 贴壁 | 上皮样 | 1 x 10^6 cells/vial/T25 |
C1200 | T-47D | 人乳腺管癌细胞 | 贴壁 | 上皮样 | 1 x 10^6 cells/vial/T25 |
C1231 | MDA-MB-157 | 人乳腺癌细胞 | 贴壁 | 上皮样 | 1 x 10^6 cells/vial/T25 |
C1249 | Hs 578Bst | 人正常乳腺细胞 | 贴壁 | 成纤维样 | 1 x 10^6 cells/vial/T25 |
C1008 | MCF7 | 人乳腺癌细胞 | 贴壁 | 上皮样 | 1 x 10^6 cells/vial/T25 |
细胞在发货前进行质检:
1、细胞存种的活性检测;
2、细菌、真菌、霉菌污染物镜检;
3、衣原体、支原体检测。
联系人:胡经理
电话:15921028707(微信同号)
:3407506161
:021-55150076
官网:https://whelab.com
公司邮箱:info@whelab.com
技术邮箱:tech@whelab.com
地址:上海宝山区呼兰西路129号8号楼4层
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
CLPUB00368
Polanowski F.P., Gaffney E.V., Burke R.E.
HBL-100, a cell line established from human breast milk.
In Vitro 12:328-328(1976)
PubMed=6891286; DOI=10.1007/BF00204786
Gaffney E.V.
A cell line (HBL-100) established from human breast milk.
Cell Tissue Res. 227:563-568(1982)
PubMed=6500159; DOI=10.1159/000163283
Gershwin M.E., Lentz D., Owens R.B.
Relationship between karyotype of tissue culture lines and tumorigenicity in nude mice.
Exp. Cell Biol. 52:361-370(1984)
PubMed=2995096; DOI=10.1016/0014-4827(85)90238-1
Caron de Fromentel C., Nardeux P.-C., Soussi T., Lavialle C., Estrade S., Carloni G., Chandrasekaran K., Cassingena R.
Epithelial HBL-100 cell line derived from milk of an apparently healthy woman harbours SV40 genetic information.
Exp. Cell Res. 160:83-94(1985)
PubMed=3109929; DOI=10.1016/0014-4827(87)90318-1
Dealtry G.B., Naylor M.S., Fiers W.C., Balkwill F.R.
The effect of recombinant human tumour necrosis factor on growth and macromolecular synthesis of human epithelial cells.
Exp. Cell Res. 170:428-438(1987)
PubMed=2840847
Marlhens F., Saint-Ruf C., Nardeux P.-C., Lavialle C., Brouty-Boye D., Dutrillaux B., Cassingena R.
Karyotype evolution of the human HBL-100 cell line and mapping of the integration site of SV40 DNA.
Ann. Genet. 31:81-86(1988)
PubMed=2547730; DOI=10.1002/ijc.2910440230
Saint-Ruf C., Nardeux P.-C., Cebrian J., Lacasa M., Lavialle C., Cassingena R.
Molecular cloning and characterization of endogenous SV40 DNA from human HBL-100 cells.
Int. J. Cancer 44:367-372(1989)
DOI=10.1016/B978-0-12-333530-2.50009-5
Leibovitz A.
Cell lines from human breast.
(In) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.161-184; Academic Press; New York (1994)
PubMed=9671407; DOI=10.1038/sj.onc.1201814
Sweeney K.J., Swarbrick A., Sutherland R.L., Musgrove E.A.
Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells.
Oncogene 16:2865-2878(1998)
PubMed=10969801
Forozan F., Mahlamaki E.H., Monni O., Chen Y.-D., Veldman R., Jiang Y., Gooden G.C., Ethier S.P., Kallioniemi A., Kallioniemi O.-P.
Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data.
Cancer Res. 60:4519-4525(2000)
PubMed=12661003; DOI=10.1002/gcc.10196
Seitz S., Wassmuth P., Plaschke J., Schackert H.K., Karsten U., Santibanez-Koref M.-F., Schlag P.M., Scherneck S.
Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines.
Genes Chromosomes Cancer 37:29-35(2003)
PubMed=16643607; DOI=10.1111/j.1749-0774.2005.00007.x
Yoshino K., Iimura E., Saijo K., Iwase S., Fukami K., Ohno T., Obata Y., Nakamura Y.
Essential role for gene profiling analysis in the authentication of human cell lines.
Hum. Cell 19:43-48(2006)
PubMed=17157791; DOI=10.1016/j.ccr.2006.10.008
Neve R.M., Chin K., Fridlyand J., Yeh J., Baehner F.L., Fevr T., Clark L., Bayani N., Coppe J.-P., Tong F., Speed T., Spellman P.T., DeVries S., Lapuk A., Wang N.J., Kuo W.-L., Stilwell J.L., Pinkel D., Albertson D.G., Waldman F.M., McCormick F., Dickson R.B., Johnson M.D., Lippman M.E., Ethier S.P., Gazdar A.F., Gray J.W.
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
Cancer Cell 10:515-527(2006)
CLPUB00423
Morrison B.J.
Breast cancer stem cells: tumourspheres and implications for therapy.
Thesis PhD (2010), Griffith University, Australia
PubMed=20143388; DOI=10.1002/ijc.25242
Capes-Davis A., Theodosopoulos G., Atkin I., Drexler H.G., Kohara A., MacLeod R.A.F., Masters J.R.W., Nakamura Y., Reid Y.A., Reddel R.R., Freshney R.I.
Check your cultures! A list of cross-contaminated or misidentified cell lines.
Int. J. Cancer 127:1-8(2010)
PubMed=24094812; DOI=10.1016/j.ccr.2013.08.020
Timmerman L.A., Holton T., Yuneva M., Louie R.J., Padro M., Daemen A., Hu M., Chan D.A., Ethier S.P., van 't Veer L.J., Polyak K., McCormick F., Gray J.W.
Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target.
Cancer Cell 24:450-465(2013)
PubMed=24176112; DOI=10.1186/gb-2013-14-10-r110
Daemen A., Griffith O.L., Heiser L.M., Wang N.J., Enache O.M., Sanborn Z., Pepin F., Durinck S., Korkola J.E., Griffith M., Hur J.S., Huh N., Chung J., Cope L., Fackler M.J., Umbricht C.B., Sukumar S., Seth P., Sukhatme V.P., Jakkula L.R., Lu Y.-L., Mills G.B., Cho R.J., Collisson E.A., van 't Veer L.J., Spellman P.T., Gray J.W.
Modeling precision treatment of breast cancer.
Genome Biol. 14:R110.1-R110.14(2013)
PubMed=25485619; DOI=10.1038/nbt.3080
Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z.-S., Liu H.-B., Degenhardt J., Mayba O., Gnad F., Liu J.-F., Pau G., Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M.-M., Zynda G.J., Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L., Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J., Settleman J., Seshagiri S., Zhang Z.-M.
A comprehensive transcriptional portrait of human cancer cell lines.
Nat. Biotechnol. 33:306-312(2015)
PubMed=26589293; DOI=10.1186/s13073-015-0240-5
Scholtalbers J., Boegel S., Bukur T., Byl M., Goerges S., Sorn P., Loewer M., Sahin U., Castle J.C.
TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.
Genome Med. 7:118.1-118.7(2015)
PubMed=28889351; DOI=10.1007/s10549-017-4496-x
Saunus J.M., Smart C.E., Kutasovic J.R., Johnston R.L., Kalita-de Croft P., Miranda M., Rozali E.N., Vargas A.C., Reid L.E., Lorsy E., Cocciardi S., Seidens T., McCart Reed A.E., Dalley A.J., Wockner L.F., Johnson J., Sarkar D., Askarian-Amiri M.E., Simpson P.T., Khanna K.K., Chenevix-Trench G., Al-Ejeh F., Lakhani S.R.
Multidimensional phenotyping of breast cancer cell lines to guide preclinical research.
Breast Cancer Res. Treat. 167:289-301(2018)
需要更多技术资料 索取更多技术资料